Combating Counterfeiting and Illegal Diversion

Unit dosage protection measures created by NanoInk's Nanoencryption technology provide complete traceability and ensure that patients are receiving the right medication.

By Jim Whittle, vice president of business development, NanoInk, Inc.

Jim Whittle, vice president of business development for NanoInk, Inc., led an interactive workshop on combating counterfeiting and illegal diversion of pharmaceuticals on Sept. 19 at the Global Pharma Manufacturing Summit in Schaumburg, Ill. Click below to access his 61-page PowerPoint presentation.

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments